zolbetuximab
astellas
[]
$alpmy - astellas to present positive findings from phase 3 spotlight trial of zolbetuximab during 2023 asco gi cancers symposium 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.